NASDAQ:ADMA
ADMA Biologics Inc Stock News
$6.55
+0.110 (+1.71%)
At Close: Apr 26, 2024
New Strong Buy Stocks for January 31st
07:05am, Wednesday, 31'st Jan 2024
ADMA, IKT, YPF, AVXL and EKSO have been added to the Zacks Rank #1 (Strong Buy) List on January 31, 2024.
Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable
09:50am, Tuesday, 30'th Jan 2024
Adma Biologics (ADMA) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Best Momentum Stocks to Buy for January 24th
11:01am, Wednesday, 24'th Jan 2024
ADMA, CM and HEAR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 24, 2023.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Wednesday, 24'th Jan 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
New Strong Buy Stocks for January 24th
06:56am, Wednesday, 24'th Jan 2024
ADMA, PBPB, YPF, CM and AVXL have been added to the Zacks Rank #1 (Strong Buy) List on January 24, 2023.
Wall Street Analysts Predict a 27.09% Upside in Adma Biologics (ADMA): Here's What You Should Know
10:56am, Friday, 19'th Jan 2024
The consensus price target hints at a 27.1% upside potential for Adma Biologics (ADMA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings es
Best Momentum Stocks to Buy for January 11th (Revised)
12:02pm, Friday, 12'th Jan 2024
ADMA and ARQT made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 11, 2024.
New Strong Buy Stocks for January 11th
08:16am, Thursday, 11'th Jan 2024
ADMA, ARQT, PHR, OPRX and PHG have been added to the Zacks Rank #1 (Strong Buy) List on January 11, 2024.
Adma Biologics (ADMA) is on the Move, Here's Why the Trend Could be Sustainable
10:32am, Wednesday, 10'th Jan 2024
Adma Biologics (ADMA) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through
Are You Looking for a Top Momentum Pick? Why Adma Biologics (ADMA) is a Great Choice
01:32pm, Friday, 05'th Jan 2024
Does Adma Biologics (ADMA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy?
10:31am, Tuesday, 26'th Dec 2023
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Should You Buy Adma Biologics (ADMA) After Golden Cross?
11:16am, Monday, 25'th Dec 2023
From a technical perspective, ADMA Biologics Inc (ADMA) is looking like an interesting pick, as it just reached a key level of support. ADMA's 50-day simple moving average crossed above its 200-day si
GSK, Hansoh Ink Deal to Develop Lung Cancer ADC Candidate
12:47pm, Thursday, 21'st Dec 2023
GSK enters into an exclusive licensing agreement with China-based Hansoh to develop and commercialize the latter's lung cancer candidate, HS-20093.
CARA's Late-Stage Skin Disease Study Fails, Stock Plummets 49%
01:32pm, Tuesday, 19'th Dec 2023
CARA discontinues the clinical program of oral difelikefalin for pruritus associated with atopic dermatitis following the failure of dose-finding Part A of the late-stage study. Stock plunges 49%.
Are Medical Stocks Lagging ADMA Biologics (ADMA) This Year?
11:17am, Wednesday, 06'th Dec 2023
Here is how Adma Biologics (ADMA) and Aurinia Pharmaceuticals (AUPH) have performed compared to their sector so far this year.
